Impurities, PQT Training May 2014 1 |1 | 1 1 3.2.S.3.2 Impurities, Malaysia, 29 September 2011 Impurities Dr Antony Fake WHO Prequalification Team - Medicines.

Slides:



Advertisements
Similar presentations
Dr. Birgit Schmauser, BfArM, Bonn
Advertisements

Stability Studies - Evaluation of Outcomes and Development of Documentation For Regulatory Submissions Bob Seevers.
Analytical Method Development and Validation
Estimation of TLD dose measurement uncertainties and thresholds at the Radiation Protection Service Du Toit Volschenk SABS.
2-4 ICH Quality Guidances: an overview
Finished Pharmaceutical Product Specifications
BPT2423 – STATISTICAL PROCESS CONTROL
Item Writing Techniques KNR 279. TYPES OF QUESTIONS Closed ended  Checking yes/no, multiple choice, etc.  Puts answers in categories  Easy to score.
Exp. 13: CALCULATION, CHROMATOGRAPHIC, AND SPECTRAL APPLICATIONS.
Reprocessing Biotech Products
Stability data required by WHO-PQP Mercy Acquaye.
Chapter 8 Critical Control Point Monitoring. Objective In this module, you will learn: u How monitoring is defined u Why monitoring is needed u How to.
1 XXXXXXXXXXXXXXXXXXX, Malaysia, XXXXXX September, S.3.2 Impurities, Malaysia, 29 September 2011 Options for submitting API data to support.
Impurities in New Drug Substances ICH Topic Q3A (R) – Revised Guidelines in Oct الشوائب في الأدوية الجديدة.
Batch Reworking and Reprocessing
World Health Organization
Specifications Breakout Session I&II
World Health Organization
Determine impurity level in relevant batches1
Validation Part 2: Cleaning validation
Chapter 9 Audit Sampling: An Application to Substantive Tests of Account Balances McGraw-Hill/Irwin ©2008 The McGraw-Hill Companies, All Rights Reserved.
Reference standards Bujji Kanchi.
Review of Analytical Methods
Auditing A Risk-Based Approach To Conducting A Quality Audit
Reference, Retention and Reserve Samples
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Chemometrics Method comparison
Radiopharmaceutical Production
Validation of Analytical Method
Criteria and Standard.
Reaching Goals: Plans and Controls
Respected Professor Kihyeon Cho
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
ITFG/IPAC Collaboration CMC Specifications Technical Team ITFG/IPAC TECHNICAL TEAM: CMC SPECIFICATIONS Presented by: Bo Olsson, PhD 26 April 2000 Rockville,
Chapter 10 Contemporary Project Management Kloppenborg
Audit Risk. "Audit risk" means the risk that the auditor gives an inappropriate audit opinion when the financial statements are materially misstated Audit.
Chapter 05 Audit Evidence and Documentation McGraw-Hill/IrwinCopyright © 2014 by The McGraw-Hill Companies, Inc. All rights reserved.
©CourseCollege.com 1 14 Inventory Inventory held for sale by retailers, manufacturers and wholesalers. Learning Objectives 1.Identify all costs and apply.
1 Impurities: Positions of the regulatory authorities (like FDA and EMA) worldwide Dr. Christian Zeine, Warsaw, Nov 18, 2014 Science for a safer world.
® HPLC Columns Inertsil ODS-4 is a C18 column developed focusing on superb inertness to basic, acidic, neutral and chelating compounds, which can virtually.
Event Management & ITIL V3
Let’s Talk Assessment Rhonda Haus University of Regina 2013.
(Dr). Santosh Kumar Narla, Formulation Regulatory Affairs,
Economics 173 Business Statistics Lecture 4 Fall, 2001 Professor J. Petry
HELM AG Module 3 Christa Clasen Ankara, 6./7. April 2006.
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on impurities Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM, Council.
Current Issues & Challenges in the Development of Pharmacopoeial Monographs: Some New Challenges in the Impurities Arena Dr. Susanne Keitel European Directorate.
1 FDA Guidance for Industry: ANDAs: Impurities in Drug Substances Published by US FDA’s Center for Drug Evaluation and Research June 2009.
Stability Indicating Assays for Dose Formulation Stability Testing Teresa Fuller GSK.
Quality Control Internal QC External QC. -Monitors a test's method precision and analytical bias. -Preparation of quality control samples and their interpretation.
Impurities in Drugs author: srikanth N
Evaluation Chapter 9. Chapter Objectives Learn: –How evaluation incorporates into the overall problem solving process. –Ethical considerations for solution.
1 Prepared by: Laila al-Hasan. 1. Definition of research 2. Characteristics of research 3. Types of research 4. Objectives 5. Inquiry mode 2 Prepared.
RISK MANAGEMENT FOR COMMUNITY EVENTS. Today’s Session Risk Management – why is it important? Risk Management and Risk Assessment concepts Steps in the.
Requirements of Documents for Quality Management System ISO 9001 Certification.
Heavy Metals: Regulatory Aspects DIA-SIG RA-CMC working group 15Mar12 Anders Neil Principal Consultant PAREXEL Consulting.
Telephone : / 82 ID: com Website: www
Question 4-1 Which of the following statements concerning noncompliance by clients is correct?    A.  An auditor's responsibility to detect noncompliance.
Quality Assurance and Quality Control in Generics
Clinical practice guidelines and Clinical audit
Dr. Birgit Schmauser, BfArM, Bonn
WHO Technical Report Series, No. 953, 2009
Introduction To Medical Technology
▪Internal quality control:
GL18 (R) – Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substance and Excipients.
Quality guidelines on impurities
Quality guidelines on impurities
GL 51 – Statistical evaluation of stability data
Evidence Based Diagnosis
Guideline for Elemental Impurities ICH Q3D(R)
Presentation transcript:

Impurities, PQT Training May |1 | S.3.2 Impurities, Malaysia, 29 September 2011 Impurities Dr Antony Fake WHO Prequalification Team - Medicines

Impurities, PQT Training May |2 |IntroductionIntroduction This presentation is made with reference to the preparation of the API. This is because the API is the source of the majority of impurities. When considering FPPs, the focus is largely on degradants, although excipient-API and leaching from containers must not be overlooked.

Impurities, PQT Training May |3 | Things we add during preparation: What kinds of impurities are there?

Impurities, PQT Training May |4 | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents What kinds of impurities are there?

Impurities, PQT Training May |5 | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents Things we unintentionally add during preparation: What kinds of impurities are there?

Impurities, PQT Training May |6 | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents Things we unintentionally add during preparation: Starting materials impurities; impurities within solvents, pesticides... What kinds of impurities are there?

Impurities, PQT Training May |7 | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents Things we unintentionally add during preparation: Starting materials impurities; impurities within solvents, pesticides... Unwanted things that are made during preparation: What kinds of impurities are there?

Impurities, PQT Training May |8 | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents Things we unintentionally add during preparation: Starting materials impurities; impurities within solvents, pesticides... Unwanted things that are made during preparation: Reaction intermediates, related-substances What kinds of impurities are there?

Impurities, PQT Training May |9 | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents Things we unintentionally add during preparation: Starting materials impurities; impurities within solvents, pesticides... Unwanted things that are made during preparation: Reaction intermediates, related-substances Things that are formed after preparation: What kinds of impurities are there?

Impurities, PQT Training May | Things we add during preparation: Solvents, metal catalysts, starting materials, reagents Things we unintentionally add during preparation: Starting materials impurities; impurities within solvents, pesticides... Unwanted things that are made during preparation: Reaction intermediates, related-substances Things that are formed after preparation: Degradation products What kinds of impurities are there?

Impurities, PQT Training May | API SM Reaction intermediate Final API Reagents Solvents Catalysts Degradation By-products SM impurities Reagents Solvents Catalysts What are the potential impurities? Potential Impurities Residue of the SM Residue of the intermediate Impurities in the SM Reagents Solvents Catalysts Reaction by-products Degradation products

Impurities, PQT Training May | Things we add during preparation: Solvents, metal catalysts – 3.2.S.2.2 Things we unintentionally add during preparation: SM impurities; impurities within solvents, pesticides S.2.3 Unwanted things that are made during preparation: Reaction intermediates (3.2.S.2.3), related-substances (3.2.S.3.2) Things that are formed after preparation: Degradation products (3.2.S.7) And of course 3.2.S.3.2 – Discussion of impurities Where do we find information on impurities?

Impurities, PQT Training May | Types of Impurities Organic impurities Related substances and Degradation products Solvents Metals Genotoxins

Impurities, PQT Training May | API Monographs You can not rely upon an API monograph entirely for potential organic impurities. Many impurities are specific to the manner of API preparation and may not have been considered when the monograph was published. Of course monographs are a great start.

Impurities, PQT Training May | Potential Organic Impurities The applicant should consider all potential impurities and then by logic, or by testing, reduce the set of potential impurities to a set of probable impurities. There are probably four categories: –Degradants –Synthetic by-products of the API –Remnants of earlier intermediates –Synthetic by products of earlier intermediates

Impurities, PQT Training May |DegradantsDegradants Degradants: Forced degradation studies will provide information on major degradants. Forced degradation studies will provide information on the acceptability of the analytical technique Monographs tend to be better at listing degradants.

Impurities, PQT Training May | Related Substances Impurities are more difficult to predict. Test method sensitivity is extremely important. What can it detect? Mass balance should be kept in mind. If there are multiple pharmacopoeial monographs, then at the very least consider all of these impurities. At least for investigation purposes.

Impurities, PQT Training May | Setting specifications

Impurities, PQT Training May | Thresholds and limits Thresholds The ICH reporting, identification, and qualification thresholds indicate levels at which the applicant is expected to undertake increasing control of an impurity. Limits In contrast an impurity limit is the non-negotiable allowable level for an impurity in a batch.

Impurities, PQT Training May |ThresholdsThresholds QF Threshold ID Threshold Reporting Threshold

Impurities, PQT Training May | This is a limit In contrast an impurity limit is the non-negotiable allowable level for an impurity in a batch.

Impurities, PQT Training May | Reporting threshold For APIs taken less then 2g per day 0.05% For APIs taken greater then 2g per day 0.03%

Impurities, PQT Training May | Exceeding the Reporting threshold QF Threshold ID Threshold Reporting Threshold

Impurities, PQT Training May | Reporting threshold Every time a peak is observed above the reporting threshold it needs to be recorded in the laboratory results. It prevents the applicant from having to report every little peak that is observed in the chromatogram. A peak above the reporting threshold does not (necessarily) need to be specified in the API specifications. However, any peak above the reporting threshold must be counted towards the Total impurity content reported in the Certificate of Analysis.

Impurities, PQT Training May | Identification threshold For APIs taken less then 2g per day The lesser of 0.10% or 1.0 mg TDI For APIs taken greater then 2g per day 0.05%

Impurities, PQT Training May | Exceeding the ID threshold QF Threshold ID Threshold Reporting Threshold

Impurities, PQT Training May | Exceeding the ID threshold If a peak is observed routinely above the ID threshold then the impurity must be: Specified individually in the API specifications (by name or RRT). Identified (or efforts made to do so)

Impurities, PQT Training May | “Routinely Observed” Normally, the decision to include an impurity in the specifications is based upon the likelihood it will occur routinely. –For instance, observed above the ID threshold in long-term stability data, or commonly occurs in batches when tested at release. An impurity only occurring in accelerated stability trials, forced degradation trials, or during development may not need to be included.

Impurities, PQT Training May | Qualification threshold For APIs taken less then 2g per day The lesser of 0.15% or 1.0 mg TDI For APIs taken greater then 2g per day 0.05% An impurity limit above the Qualification threshold must be known to be safe.

Impurities, PQT Training May | Exceeding the QF thresholds QF Threshold ID Threshold Reporting Threshold

Impurities, PQT Training May | Justifying a limit exceeding the Qualification Threshold Refer to a limit in a recognised monograph- WARNING – it must be a specified Impurity. …Impurity A, no more than 0.25% - OK …Any impurity no more than 0.5% - Not OK Present literature evidence in support of the limit. Present the results of toxicological studies supporting the safety of the limit. Set the limit to 0.15% (or 1 mg TDI) and modify the process to meet this limit.

Impurities, PQT Training May | The lesser of 0.15% or 1.0 mg TDI

Impurities, PQT Training May | Example 1 A peak is observed at 0.086%. Is this above the Qualification threshold? At 800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.15% Reported peakEquivalent in mgAbove QF threshold?

Impurities, PQT Training May | Example 1 A peak is observed at 0.086%. Is this above the Qualification threshold? At 800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15% Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Example 1 A peak is observed at 0.086%. Is this above the Qualification threshold? At 800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Example 1 A peak is observed at 0.086%. Is this above the Qualification threshold? At 800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%0.72 mg

Impurities, PQT Training May | Example 1 A peak is observed at 0.086%. Is this above the Qualification threshold? At 800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%0.72 mgNo

Impurities, PQT Training May | Example 2 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1150 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15% Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Example 2 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1150 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Example 2 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1150 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%1.035 mg

Impurities, PQT Training May | Example 2 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1150 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%~1.0 mg

Impurities, PQT Training May | Example 2 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1150 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%~1.0 mgNo

Impurities, PQT Training May | Example 3 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Example 3 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.15%No Reported peakEquivalent in mgAbove QF threshold? 0.09%1.62 mg

Impurities, PQT Training May | Example 3 A peak is observed at 0.086%. Is this above the Qualification threshold? At 1800 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.10%No Reported peakEquivalent in mgAbove QF threshold? 0.09%1.6 mgYes

Impurities, PQT Training May | Example 4 A peak is observed at 0.086%. Is this above the Qualification threshold? At 2500 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09% Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Example 4 A peak is observed at 0.086%. Is this above the Qualification threshold? At 2500 mg total daily dose Reported peakThresholdAbove QF threshold? 0.09%0.05%Yes Reported peakEquivalent in mgAbove QF threshold? 0.09%

Impurities, PQT Training May | Relative response factors API Imp A Imp B Which impurity peak is bigger? UV Abs

Impurities, PQT Training May | Relative response factors API Imp A Imp B Which impurity is present in the greater amount? UV Abs

Impurities, PQT Training May | Relative response factors API Imp A Imp B Which impurity is present in the greater amount? It is impossible to tell without further information. UV Abs

Impurities, PQT Training May | The size of a peak in a chromatogram is determined by the amount of impurity present, but also how well it responds to the detector. In HPLC-UV techniques the response is due to the inherent UV absorbance of the impurity at the detected wavelength. Some impurities will not be detected at all! RRF = Response of Imp/Response of API, but always check the formula just in case the ratio is described differently. Relative response factors

Impurities, PQT Training May | Response factors At the time of initial development and investigation it is assumed the response factor = 1. For reporting thresholds it is assumed the response factor = 1. When impurities are identified their response factor must be considered. The RRF for all identified impurities should be established.

Impurities, PQT Training May | Relative response factors When an RRF of between 0.8 to 1.2 is it not mandatory to apply the correction. The use of a RRF could shift an observed impurity from one threshold to another. This is often of benefit to the applicant. If the response of an impurity is greater than the equivalent amount of API (RRF>1) it could mean a peak no longer exceeds the Qualification threshold.

Impurities, PQT Training May |ConclusionConclusion The applicant should discuss the possible generation of related substances in 3.2.S.3.2 They must undertake a rigorous testing investigation, including use of appropriate test methods. Monographs are an excellent source of information on possible related substances and degradation impurities but are not complete. When applying thresholds consider TDI and RRF of the impurity

Impurities, PQT Training May | Further information Please feel free to ask me any questions now or later. Or me at: Thank you